| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
3.71 -0.09 (-0.02%) |
10-17 15:14 |
|
Open: |
3.8 |
Pre close: |
3.8 |
Target:
|
5.48
|
|
High: |
3.85 |
Low: |
3.63 |
Resistance:
|
4.69
5.46
|
|
Volume: |
286,765 |
Market Cap: |
105M |
Support:
|
3.44
2.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.68
 |
MACD |
MACD(12,26):
|
-0.14  |
|
MA(20): |
4.22 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
3.70 |
Stochastic Oscillator |
%K(14,3):
|
13.53 |
|
MA(250): |
3.49 |
%D(3): |
12.76 |
|
Average Volume(K) |
3-Month: |
70183
|
52-Week |
High:
|
5.83 |
|
10-Days: |
57161 |
Low: |
1.71 |
|
RSI |
RSI(14):
|
41.23 |
Change(%): |
61.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.970 |
Return on Equity (ttm) |
-131.0 |
Shares Out. (M) |
28.42 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-48.6 |
Shares Float (M) |
27.70 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
178.9 |
% Held by Institutions |
60.80 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.093 |
Shares Short (K) |
3906 |
|
Book Value (p.s.) |
3.730 |
EBITDA (p.s.) |
-0.168 |
P/E |
-3.76 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.98 |
|
Profit Margin |
-66.10 |
Operating Cash Flow
(M) |
-13.99 |
P/S |
96946736.00 |
|
Operating Margin |
-77.66 |
Levered Free Cash Flow
(M) |
-9.50 |
P/CF |
-7.42 |
|
|
|
|
|
|
